Covered recipient · General Payments record
KALLIE T FEHR
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2024–2025
$429.34
- Reported across 22 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $360.68 | 18 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $83.84 | 4 |
| Lilly USA, LLC | $78.70 | 4 |
| Exact Sciences Corporation | $56.03 | 2 |
| Novo Nordisk AS | $38.46 | 2 |
| Acerta Pharma LLC | $33.69 | 2 |
| PFIZER INC. | $22.46 | 1 |
| Amgen Inc. | $16.47 | 1 |
| GlaxoSmithKline, LLC. | $15.58 | 1 |
| Phathom Pharmaceuticals, Inc. | $15.45 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.54 | 01/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201844984 | CMS |
| ABBVIE INC. | $23.24 | 03/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201844986 | CMS |
| ABBVIE INC. | $21.16 | 03/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201844988 | CMS |
| ABBVIE INC. | $22.90 | 09/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201844990 | CMS |
| Amgen Inc. | $16.47 | 04/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228347150 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.09 | 06/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206155856 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.60 | 11/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206444422 | CMS |
| Exact Sciences Corporation | $28.00 | 04/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235252293 | CMS |
| Exact Sciences Corporation | $28.03 | 06/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235252309 | CMS |
| GlaxoSmithKline, LLC. | $15.58 | 03/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1190360891 | CMS |
| Lilly USA, LLC | $19.02 | 04/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186730637 | CMS |
| Lilly USA, LLC | $24.93 | 06/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186711193 | CMS |
| Lilly USA, LLC | $17.75 | 07/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186740079 | CMS |
| Lilly USA, LLC | $17.00 | 09/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186658963 | CMS |
| Novo Nordisk Inc | $19.88 | 02/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188679907 | CMS |
| Novo Nordisk Inc | $18.58 | 04/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188133359 | CMS |
| PFIZER INC. | $22.46 | 07/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1229364974 | CMS |
| Phathom Pharmaceuticals, Inc. | $15.45 | 04/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1219312743 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2024, 2025
- Source files
- Dataset page · Bulk file · PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.